Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

NCT06318871 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Renal Carcinoma
Renal Cell Carcinoma
Urothelial Carcinoma
Chromophobe Renal Cell Carcinoma
Translocation Renal Cell Carcinoma

Interventions

BIOLOGICAL: Cytokine Induced Memory-like Natural Killer (CIML NK) Cells
DRUG: Interleukin-2 (IL-2)

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]